TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
林靜嫻LIN, CHIN-HSIEN
- Principal Investigator
- Clinical Trial Experience (year) 12 years 9 個月
Publication
25Publications
21
Lin, C. H., Chen, P. L., Tai, C. H., Lin, H. I., Chen, C. S., Chen, M. L., & Wu, R. M. (2019). A clinical and genetic study of early-onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing. Movement Disorders, 34(4), 506-515. https://doi.org/10.1002/mds.27633
22
Lin, C. H., Li, C. H., Yang, K. C., Lin, F. J., Wu, C. C., Chieh, J. J., & Chiu, M. J. (2019). Blood NfL A biomarker for disease severity and progression in Parkinson disease. Neurology, 93(11), E1104-E1111. https://doi.org/10.1212/wnl.0000000000008088
23
Lin, H. I., Cheng, Y. C., Ko, H. W., Wen, C. H., Lu, H. E., Huang, C. Y., Hsieh, P. C. H., & Lin, C. H. (2019). Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation. Stem Cell Research, 37, Article 101447. https://doi.org/10.1016/j.scr.2019.101447
24
Su, T. H., Yang, H. C., Tseng, T. C., Chou, S. W., Lin, C. H., Liu, C. H., Liu, C. J., Chen, C. L., & Kao, J. H. (2019). Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism. Movement Disorders, 34(12), 1882-1890. https://doi.org/10.1002/mds.27848
25
Vollstedt, E. J., Kasten, M., Klein, C., & D, M. G. G. P. (2019). Using global team science to identify genetic parkinson's disease worldwide. Annals of Neurology, 86(2), 153-157. https://doi.org/10.1002/ana.25514
